EIQ.AX is trading 27.4% up today at A$1.58 after announcing a strategic investment and U.S. distribution partnership with Pro Medicus.

  • The framework deal provides up to A$20 million in funding via secured convertible notes and debt to support Echo IQ’s growth initiatives.
  • Pro Medicus will serve as a reseller of the EchoSolv AI cardiology product suite in the U.S. market, significantly expanding the company's commercial reach.
  • The partnership has bolstered investor confidence regarding the rapid commercialisation and scaling of Echo IQ’s AI-driven diagnostic tools.